Live
Home·Deals·Healthcare·BioNTech SE acquires CureVac
BioNTech SE acquires CureVac (2026)
SEO URLwww.firestrike.ai/deals/curevac-biontech-se-acquisition-2026
acquisitionAnnounced · Jan 3, 2026HealthcareSource · CredibleArticle · Factual
CureVac
BioNTech SE
CureVac · BioNTech SE

BioNTech SE acquires CureVac

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
CureVac
CureVac
Tuebingen, Baden-Wuerttemberg
Acquirer
BioNTech SE
BioNTech SE
Full Acquisition
Status
Announced

BioNTech SE agreed to acquire CureVac. Reported deal value: Undisclosed. Status: Announced. Sector: Healthcare. Target headquarters context: Tuebingen, Baden-Wuerttemberg, Germany.

This page summarizes publicly available information about the transaction as of 2026-01-03. Figures and status may change as filings and press coverage update.

Should investors sell immediately? Or is it worth buying CureVac ? Acquiring Entity: BioNTech SE Stake Secured: Roughly 86.75% of CureVac shares Offer Closure: December 18, 20 25 Squeeze-Out Execution: January 20 26 Final Outcome: Delisting of CureVac equity Share Price Dynamics Shift from Fundamentals to Mechanics CureVac stock performance has decoupled from operational developments

Deal timeline

Announced
Jan 3, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Healthcare. Figures and status may change as sources update.

Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index